Literature DB >> 12967810

Prevalence of ciliochoroidal effusion after prophylactic laser iridotomy.

Hiroshi Sakai1, Hideo Ishikawa, Manabu Shinzato, Yoshimi Nakamura, Miyako Sakai, Shoichi Sawaguchi.   

Abstract

PURPOSE: To study the prevalence of ciliochoroidal effusion (CE) after prophylactic laser iridotomy (LI).
METHODS: An ultrasound biomicroscope (UBM) examination was performed before, 2, and 24 hours after LI to investigate the changes in supraciliary-choroidal space after LI in circumference of 38 eyes in 23 chronic primary angle-closure patients. Subjects were divided randomly into two groups based on LI settings: 21 eyes by argon laser (Ar-LI group) and argon combined with yttrium-aluminum-garnet (YAG) laser in 17 eyes (Ar-YAG-LI group). Ciliochoroidal effusion was observed predominantly in the inferior sector (12 of 12 eyes, 100%) and rare in nasal part of the eyes (4 of 12 eyes, 33%). Ciliochoroidal effusion appeared more often in the Ar-LI group (10 eyes, 52%) than in the Ar-YAG-LI group (2 eyes, 12%). All CE disappeared 7 days after by UBM observation.
CONCLUSIONS: Subclinical CE observed by UBM frequently occurs after LI.

Entities:  

Mesh:

Year:  2003        PMID: 12967810     DOI: 10.1016/s0002-9394(03)00238-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Recurrent Uveal Effusion after Laser Iridotomy.

Authors:  Hiroshi Sakai; Michiko Yonahara; Miyako Sakai
Journal:  Case Rep Ophthalmol       Date:  2017-01-17

2.  Extensive serous ciliochoroidal detachments and macular subretinal and intraretinal fluid following laser peripheral iridotomy.

Authors:  Devin Betsch; Amr Zaki; Jeremy Murphy; Hesham Lakosha; R Rishi Gupta
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-15

3.  Surgical peripheral iridectomy via a clear-cornea phacoemulsification incision for pupillary block following cataract surgery in acute angle closure.

Authors:  Aiwu Fang; Peijuan Wang; Rui He; Jia Qu
Journal:  BMC Ophthalmol       Date:  2018-05-18       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.